Updated ECDC risk assessment on the spread of New Delhi metallo-β-lactamase (NDM) and its variants within Europe
Data currently available from scientific publications and enhanced surveillance in some EU Member States indicate that there is an increase in the spread of all carbapenemase-producing Enterobacteriaceae (CPE) in Europe, including New Delhi metallo-β-lactamase (NDM).
One of the major barriers to our understanding of the magnitude of risk that these highly antibiotic-resistant bacteria represent for Europe is that EU Member States lack systematic surveillance systems and policies to detect NDM infection. Public health preparedness should be enhanced by developing the necessary infrastructure to prevent further spread of all CPE in EU Member States, for example by introducing EU-wide surveillance to improve the monitoring of antibiotic-resistant bacteria.
This report represents a review of medical publications on New Delhi metallo-β-lactamase and its variants within Europe and a summary of the results of a survey sent to the ECDC National Antimicrobial Resistance Focal Points in all EU Member States, Iceland and Norway. The purpose of this survey was to register all cases of NDM colonisation or infection by country and to collect data on patient characteristics and epidemiological histories.
Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update
25 Mar 2020 - On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus as the causative agent of this outbreak, coronavirus disease 2019 (COVID-19).
Rapid risk assessment: Novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update
12 Mar 2020 - Since ECDC’s fifth update on novel coronavirus published on 2 March 2020 and as of 11 March, the number of cases and deaths reported in the EU/EEA and the UK has been rising, mirroring the trends seen in China in January-early February and in northern Italy in late February. If this trend continues, based on the quick pace of growth of the epidemic observed in China and northern Italy, it is likely that in days, or a small number of weeks, similar situations may be seen in other EU/EEA Member States and the UK.
Rapid risk assessment: Outbreak of novel coronavirus disease 2019 (COVID-19): increased transmission globally – fifth update
2 Mar 2020 - As of 2 March, 66 countries have reported cases of of novel coronavirus disease 2019. The risk associated with COVID-19 infection for people in the EU/EEA and UK is currently considered to be moderate to high, based on the probability of transmission and the impact of the disease.